Technology

Solutions

Pipeline

About

Resources

Request Access

Request Access

AI-Powered Discovery Pipeline

Our technology extends to a wide range of complex diseases.

Our technology extends to a wide range of complex diseases.

Oncology

Cancers are mosaics with inter- and intra-tumor heterogeneity, evolving clones, and microenvironmental effects; multi-omics unifies genomic, transcriptomic, proteomic, and spatial signals to reveal actionable subtypes and vulnerabilities.

Autoimmune

Diverse genetic risk, epigenetic priming, and tissue-specific immune circuits create overlapping phenotypes; multi-omics resolves endotypes and pathways to guide targeted, patient-specific immunomodulation.

Neurodegenerative

Nexomic’s AI-powered platform for biopharma and translational research teams, accelerating the development of targeted diagnostics and therapies. It transforms multi-omic data into explainable insights, enabling the discovery of novel biomarkers, therapeutic targets, and precise trial designs.

Cardiometabolic

Nexomic’s AI-powered platform for biopharma and translational research teams, accelerating the development of targeted diagnostics and therapies. It transforms multi-omic data into explainable insights, enabling the discovery of novel biomarkers, therapeutic targets, and precise trial designs.

Psychiatric

Nexomic’s AI-powered platform for biopharma and translational research teams, accelerating the development of targeted diagnostics and therapies. It transforms multi-omic data into explainable insights, enabling the discovery of novel biomarkers, therapeutic targets, and precise trial designs.

Oncology

Cancers are mosaics with inter- and intra-tumor heterogeneity, evolving clones, and microenvironmental effects; multi-omics unifies genomic, transcriptomic, proteomic, and spatial signals to reveal actionable subtypes and vulnerabilities.

Autoimmune

Diverse genetic risk, epigenetic priming, and tissue-specific immune circuits create overlapping phenotypes; multi-omics resolves endotypes and pathways to guide targeted, patient-specific immunomodulation.

Neurodegenerative

Nexomic’s AI-powered platform for biopharma and translational research teams, accelerating the development of targeted diagnostics and therapies. It transforms multi-omic data into explainable insights, enabling the discovery of novel biomarkers, therapeutic targets, and precise trial designs.

Cardiometabolic

Nexomic’s AI-powered platform for biopharma and translational research teams, accelerating the development of targeted diagnostics and therapies. It transforms multi-omic data into explainable insights, enabling the discovery of novel biomarkers, therapeutic targets, and precise trial designs.

Psychiatric

Nexomic’s AI-powered platform for biopharma and translational research teams, accelerating the development of targeted diagnostics and therapies. It transforms multi-omic data into explainable insights, enabling the discovery of novel biomarkers, therapeutic targets, and precise trial designs.

Oncology

Cancers are mosaics with inter- and intra-tumor heterogeneity, evolving clones, and microenvironmental effects; multi-omics unifies genomic, transcriptomic, proteomic, and spatial signals to reveal actionable subtypes and vulnerabilities.

Autoimmune

Diverse genetic risk, epigenetic priming, and tissue-specific immune circuits create overlapping phenotypes; multi-omics resolves endotypes and pathways to guide targeted, patient-specific immunomodulation.

Neurodegenerative

Overlapping proteinopathies, cell-type–specific vulnerability, and progressive network failure drive heterogeneity; multi-omics (including single-cell/spatial) maps pathogenic pathways to stratify disease and prioritize interventions

Cardiometabolic

Gene–environment interactions across liver, muscle, adipose, heart, and microbiome yield mixed phenotypes; multi-omics links variants to pathways and traits to sharpen risk stratification and therapeutic choice

Psychiatric

Polygenic architecture, developmental trajectories, and brain–immune–metabolic crosstalk blunt single biomarkers; multi-omics integrates layers to uncover mechanistic subtypes and predictors of treatment response.

Our unique pipeline.

Oncology

Autoimmune

Colorectal

Cancer

Lung Cancer

Breast Cancer

Rheumatoid Arthritis

Endotype

Biomarker

Response

Progression

Precise Therapy

Oncology

Autoimmune

Colorectal

Cancer

Lung Cancer

Breast Cancer

Rheumatoid Arthritis

Endotype

Biomarker

Response

Progression

Precise Therapy

Oncology

Autoimmune

Colorectal

Cancer

Lung Cancer

Breast Cancer

Rheumatoid Arthritis

Endotype

Biomarker

Response

Progression

Precise Therapy

Nexomic in Action

Explore the Power of NexGen Precision

Request access and we’ll tailor a brief

walkthrough to your use case

Request Access

Request Access

Nexomic in Action

Explore the Power of NexGen Precision

Request access and we’ll tailor a brief

walkthrough to your use case

Request Access

Request Access

Dublin, Ireland

Pages

Solutions

Precision Studio

© 2025 · Nexomic™ · All rights reserved